Skip to main content
. 2017 Aug 2;12(8):e0181840. doi: 10.1371/journal.pone.0181840

Table 2. Clinical data of probands carrying putative pathogenic mutations.

Patient
Familial status Sex Age at diagnosis Family history TWI Epsilon waves SA-ECG Arrhythmia RV LV
dys
TF criteria Clinical status Suspected gene
QT4286 Proband F 17 abs V1-V5 (Maj) abs + (min) > 500 PVC (min) Maj abs 2Maj/
1min
Affected EYA4
QT7052 Proband F 21 abs0 V1-V4 (Maj) abs abs NSVT (min) Maj abs 2Maj/
1min
Affected RBM20
1–46767 Proband M 34 + (min) 0 abs + (min) NSVT (min) Borderline abs 3min Borderline COX15
QT4029 Proband M 46 abs V1-V4 (Maj) abs + (min) Sustained VT (Maj) Maj abs 3Maj/
1min
Affected PSEN1

M: male; F: female; Maj/min/abs: major/minor/absent criterion of the International 2010 ARVC Task Force; TF criteria: task force criteria; TWI: T wave inversion; SAECG: signal-average ECG; RVOT VT: ventricular tachycardia from right ventricular outflow tract; PVC: premature ventricular complex; RV: right ventricle; LV dys: left ventricle dysfunction; SCD: sudden-cardiac-death; NSVT: non-sustained VT; NA: non-available data.